New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - methylprednisolone 4mg; methylprednisolone 4mg - tablet - 4 mg - active: methylprednisolone 4mg excipient: calcium stearate lactose monohydrate liquid paraffin purified water sucrose active: methylprednisolone 4mg excipient: calcium stearate lactose monohydrate maize starch purified water sucrose - primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance). · congenital adrenal hyperplasia. · nonsuppurative thyroiditis · hypercalcemia associated with cancer

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pfizer sa-nv - methylprednisolone 4 mg - tablet - 4 mg - methylprednisolone 4 mg - methylprednisolone

Canada - English - Health Canada

pfizer canada ulc - methylprednisolone - tablet - 4mg - methylprednisolone 4mg - adrenals

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

pfizer pharmaceuticals inc. - methylprednisolone - white tablet with split line, major axis: 8.2 mm, minor axis: 5.6 mm, thickness: 2.2 mm

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - methylprednisolone -

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pfizer sa-nv - methylprednisolone 4 mg - tablet - 4 mg - methylprednisolone 4 mg - methylprednisolone

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

pfizer - methylprednisolone - tablet - 4 mg

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

modern pharmaceutical company italy - 30's hdpe bottle - tablet - 4mg/tablet - endocrine system-corticosteroids

Kenya - English - Pharmacy and Poisons Board

pfizer laboratories limited 197 lenana road - nairobi - methylprednisolone - tablet - 4mg - plain weak corticosteroids (group i) for topical

United States - English - NLM (National Library of Medicine)

stat rx usa - methylprednisolone (unii: x4w7zr7023) (methylprednisolone - unii:x4w7zr7023) - methylprednisolone 4 mg - medrol tablets are indicated in the following conditions: primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance). congenital adrenal hyperplasia nonsuppurative thyroiditis hypercalcemia associated with cancer as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy) ankylosing spondylitis acute and subacute bursitis synovitis of osteoarthritis acute nonspecific tenosynovitis post-traumatic osteoarthritis psoriatic arthritis epicondylitis acute gouty arthritis during an exacerbation or as maintenance therapy in selected cases of: systemic lupus erythematosus systemic dermatomyositis (polymyositis) acute rheumatic carditis bullo